JFL Life Sciences

JFL Life Sciences

12.90
0.00
(0.00%)
hide
Key Fundamentals
Add Ratio
Market Cap
42.56 Cr
EPS
1.26
PE Ratio
12.06
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
37.15
52 Week Low
11.85
PB Ratio
1.01
Debt to Equity
0.22
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,784.10
#1 4,28,065.35
40.27
#1 54,729.00
9.71
#1 10,980
2.89
74.53
6,454.00
1,71,333.42
69.17
9,712.00
18.67
2,191
35.10
46.81
3,731.40
1,26,287.53
59.99
11,539.40
6.99
1,911
30.46
56.17
1,526.80
1,23,327.89
22.52
28,409.50
7.12
5,291
3.71
47.29
1,250.20
1,04,343.41
#1 18.09
33,741.20
16.73
5,725
-0.38
54.25
930.20
93,599.89
18.57
23,511.00
18.55
4,615
34.60
33.90
2,025.40
92,511.06
21.51
22,909.50
13.74
3,306
#1 72.75
57.78
2,223.10
91,760.34
51.75
12,744.20
#1 20.90
2,007
-21.05
29.21
1,235.80
71,775.46
21.23
32,345.60
9.43
3,484
3.81
74.03
5,724.00
68,439.01
28.33
13,458.30
3.70
2,216
10.98
64.07
Growth Rate
Revenue Growth
74.31 %
Net Income Growth
27.27 %
Cash Flow Change
-141.97 %
ROE
13.58 %
ROCE
38.94 %
EBITDA Margin (Avg.)
-7.66 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
32
30
33
35
45
47
82
75
Expenses
31
28
31
28
39
42
74
67
EBITDA
1
2
2
6
6
5
8
8
Operating Profit %
4 %
6 %
7 %
16 %
9 %
10 %
10 %
11 %
Depreciation
0
0
0
0
0
0
1
1
Interest
1
1
1
2
1
1
1
1
Profit Before Tax
0
1
1
4
4
4
6
5
Tax
0
0
0
1
1
1
2
1
Net Profit
0
0
1
3
3
3
4
4
EPS in ₹
0.59
0.66
0.89
4.12
2.90
1.00
1.26
1.10

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
16
24
29
48
49
57
72
Fixed Assets
3
5
7
7
7
13
12
Current Assets
14
18
21
39
41
44
60
Capital Work in Progress
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
Other Assets
14
19
23
41
42
44
60
Total Liabilities
16
24
29
48
49
57
72
Current Liabilities
8
18
14
28
15
21
32
Non Current Liabilities
3
1
8
9
2
1
1
Total Equity
5
5
7
11
32
36
40
Reserve & Surplus
5
5
6
3
21
25
7
Share Capital
0
0
1
8
11
11
33

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
-0
0
-0
0
0
Investing Activities
-1
-3
-2
-1
1
-6
0
Operating Activities
-3
3
-6
2
-9
8
-4
Financing Activities
4
-0
7
-2
8
-2
4

Share Holding

% Holding
Apr 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
92.52 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
67.47 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
27.69 %
29.90 %
28.48 %
28.80 %
28.06 %
28.37 %
28.77 %
28.95 %
28.88 %
Others
7.48 %
4.84 %
2.64 %
4.06 %
3.73 %
4.47 %
4.16 %
3.76 %
3.58 %
3.66 %
No of Share Holders
21
1,260
921
873
832
825
966
997
1,022
998

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Sept 2024 DIVIDEND Dividend
₹ 0.25 /share
13 Sept 2024 65.15 68.20
23 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2024 60.25 66.00
24 Sept 2024 BONUS Bonus
2:1
24 Sept 2024 66.00 66.70
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 23.30 29.45
08 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Apr 2025 16.60 17.35
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 17.75 21.45
11 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Aug 2025 14.05 14.25
28 Oct 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
28 Oct 2025 12.95 13.10
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 13.80 13.50

Technical Indicators

RSI(14)
Neutral
46.78
ATR(14)
Less Volatile
1.36
STOCH(9,6)
Neutral
31.25
STOCH RSI(14)
Neutral
27.25
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
19.33
UO(9)
Bearish
84.62
ROC(12)
Uptrend But Slowing Down
3.20
WillR(14)
Overbought
-14.00